[go: up one dir, main page]

Zhang, 2001 - Google Patents

PTIP, a novel BRCT domain-containing apoptotic factor that directly promotes cytochrome c release from mitochondria to cytoplasm

Zhang, 2001

Document ID
16277165100588731593
Author
Zhang Y
Publication year

External Links

Snippet

Release of cytochrome c from mitochondria is the key event in caspase activation during apoptosis. Although it is well documented that Bcl-2 family members regulate cytochrome c release, little is known about the direct involvement in this event of other factors. In an effort …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Wu et al. Bax and BH3-domain-only proteins in p53-mediated apoptosis
Quinn et al. Buffy, a Drosophila Bcl‐2 protein, has anti‐apoptotic and cell cycle inhibitory functions
Larisch et al. A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif
EP2010565B1 (en) Method for recombinant protein production in cho cells
US20070036775A1 (en) Method of modulating or examining Ku70 levels in cells
WO2002068465A9 (en) Novel p53-inducible protein
Zhang PTIP, a novel BRCT domain-containing apoptotic factor that directly promotes cytochrome c release from mitochondria to cytoplasm
de Melo et al. NOA36/ZNF330 is a conserved cystein-rich protein with proapoptotic activity in human cells
Liďák Novel substrates of cullin-RING ubiquitin ligases: identification and functional characterisation
US20040248775A1 (en) Methods for screening inhibitors of apoptosis
US7618787B2 (en) Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
US20040053839A1 (en) Method of protecting cells against apoptosis and assays to identify agents which modulate apoptosis
Eichler Disruption of p54nrb's gene regulatory function by caspase-2 exhibits a multifaceted role in tumor cell death susceptibility
Lin et al. A maternally encoded nuclear envelope protein required for embryonic mitosis in Drosophila
Pochampally A study of MDM2 and p53 homologues
Agapite Genetic analysis of programmed cell death in Drosophila melanogaster
Lagace Genomic Organization of the X-linked Inhibitor of Apoptosis and Identification of a Novel Testis-specific Homologue
Jasti Characterization of BBP-1, a novel pro-apoptotic protein: Functional analysis and subcellular localization studies
McLaughlin Investigating Dlx and Zbed1 Protein Interactions During Cell Cycle Progression
Brezniceanu-Mehedinti Identification of mammalian proteins inhibiting apoptosis downstream of cytochrome c release in a yeast survival screen
Manchen Characterization and subcellular localization of the human BAT3 protein.
Morgese Identification of putative interactors of Fanconi anaemia proteins by yeast to hybrid system: characterization of two novel genes highly expressed during spermatogenesis
Shen Adenovirus E1B 19K protein blocks E1A-induced, p53-mediated apoptosis at multiple death checkpoints
Skepu Identification and characterisation of a novel gene, DWNN, isolated from promoter-trapped Chinese hamster ovary cells
Balaraman An investigation of the mechanism of cisplatinum-induced apoptosis in SH-SY5Y neuroblastoma cells